Geographic Barriers to CAR-T Therapy

CAR-T is a potentially lifesaving option for some CLL patients, but Medicare reimbursement may put it out of reach The CLL Society is part of a working group of other blood cancer nonprofits that are trying to find a long term remedy for how to pay for this therapy. Read more.

The Future of CAR-T Therapy: Can CAR-T Cure CLL?
October 1, 2020

Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma
July 27, 2020

Testimonial: Dan & Jodi Symes in praise of CAR-T
June 15, 2020

Updated Results from Phase 1b/2 Study of BCMA CAR-T Therapy JNJ-4528 Shows Early, Deep and Durable Responses in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma
May 18, 2020

Proposed Changes to Reimbursement to Help Pay for CAR-T Therapy for Patients Covered by Medicare or Medicaid
May 18, 2020

A Petition to CMS for Medicare Reimbursement for Use of CAR-T
April 27, 2020